(MENAFN- Khaleej Times) Hospitals across the region are rapidly adopting connected‐care technologies as they search for safer, more efficient ways to manage medication delivery and patient monitoring.

Hospitals across the region are rapidly adopting connected‑care technologies as they search for safer, more efficient ways to manage medication delivery and patient monitoring. The shift reflects a ...

Revenue of $5.3 billion increased 1.6% as reported, 0.4% FXN New BD revenue increased 2.5% FXN GAAP and adjusted diluted EPS of $1.34 and $2.91, respectively Combination of BD's Biosciences and ...

Amount reflects the estimated impact to adjusted diluted earnings per share for fiscal year 2025 from the proposed disposition of the Bioscience and Diagnostics Solutions business that will be ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 first quarter, which ended December 31, 2025.

Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report first-quarter fiscal 2026 results on Feb. 9, before market open. In the last reported quarter, the company’s adjusted ...

BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced Tuesday that Thomas Civik has been appointed Interim Chief Executive Officer, effective immediately. Civik, who has served on the company’s board ...

In July, Becton, Dickinson and Company agreed to spinoff its biosciences and diagnostic solutions business, combining the asset with Waters Corporation, creating a new life science and diagnostics ...

MOL PLUS has decided to invest in Pyxis Maritime, a Singapore-based developer of electric vessels and operator of electric boat charging stations, as part of efforts to promote the commercialization ...

The Neopak XtraFlow glass prefillable syringe. [Image courtesy of BD] BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska ...